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Species Variations in the Pathways
of Drug Metabolism
by R. T. WiIIiams*
The basic pattern of the metabolism of foreign
compounds is the same in all species, in that most
foreign compounds are metabolized in two phases,
in the first ofwhich the compound may be oxidized,
reduced, or hydrolyzed and in the second the prod-
ucts of the first phase may undergo a synthesis or
conjugation to form polar excretory products.
Within this pattern, however, tremendous varia-
tions can occur, since the enzymes which catalyze
the reactions ofthese phases can be influenced by a
large number of factors, species being one of the
most important of these factors. Species variations
in the nature and extent ofthe biotransformation of
foreign compounds are complex and sometimes un-
expected. If any foreign compound (or xenobiotic)
is administered to more than one species, although
one can now predict the pathways of xenobiotic
metabolism, it is almost certain that species differ-
ences in the amounts of the predicted metabolites
formed and excreted will be found and in some
cases gross differences in the actual routes of
metabolism will be found.
The metabolism ofa xenobiotic is often related to
its toxicity and its therapeutic activity, and since the
testingofpotentially usefulchemicals foruse in man
is carried out in animals lower on the evolutionary
scale than man, it is important to know whether
tests on these animals can be extrapolated to man.
Therefore a comparative study of metabolism in
man and other species could be of value for
suggesting a species likely to be useful for compar-
ing the activity of a given compound with that in
man. This is abig task, since thousands ofchemical
compounds are now used by man for various pur-
poses and there are thousands ofspecies ofanimals
available for comparison; for example, there are
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1729 species of rodents, only a few of which are
extensively used for testing (e.g., the rat) and 193
species of subhuman primates which are nearest to
man on the accepted evolutionary scale. Apartfrom
testing chemicals for safe use in man, there is also
the problem of the toxicity of environment chemi-
cals to wild life. Some species may be more sensi-
tive than others to chemical pollutants, and this
difference may wellbe related to species differences
in metabolism and how the chemical is detoxicated
and excreted by the animal.
In studies, of comparative metabolism, there are
obviously two main entities to be considered: the
species and the compound; one can thus study the
fate ofone compound in many species or the fate of
many compounds in one species.
The study of one compound in many species has
produced certain patterns and from this type of
study there has emerged the suggestion that the
animals nearest to man in the pathways of drug
metabolism are the subhuman primates, particu-
larly, the Old World monkeys (1, 2). Examples of
compounds which have been studied in this way are
phenylacetic acid (3), sulfadimethoxine (4), quinic
acid (5), coumarin (6), 4-hydroxy-3,5-diiodoben-
zoate (7), and methanol (8). These studies show that
Old World monkeys and sometimes New World
monkeys are similar to man in both phase I and II
reactions; the 7-hydroxylation of coumarin, the
oxidation of methanol, and the aromatization of
quinic acid are phase I reactions, and the conjuga-
tion of phenylacetic acid with glutamine and/or
glycine and of sulfadimethoxine with glucuronic
acid, and the methylation of 4-hydroxy-3,5-
diiodobenzoate are phase II reactions.
The study ofthe fate of many compounds in one
species, usually the rat or rabbit, has been the prin-
cipal pattern ofdrug metabolism research for over a
century and has produced our main basic knowledge
ofthe metabolism offoreign compounds. From this
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closely related compounds should be metabolized
similarly in a given species. However, this sugges-
tion is only partly true, as illustrated below with the
amphetamines, arylacetic acids, and phenols.
Comparative Metabolism of
Amphetamine
One can predict that there are two points at which
amphetamine could be attacked metabolically,
namely, the ring and side chain. The ring is likely to
be hydroxylated mainly in the para position,
whereas the side chain would undergo deamination
and subsequent degradation. In the rat, the major
metabolite of amphetamine is p-hydroxyam-
phetamine, and there is but little attack on the side
chain. One could therefore predict that the main
metabolic attack on other amphetamines in the rat
would be p-hydroxylation. This has been found to
be true with methamphetamine, ephedrine,
norephedrine, phenmetrazine, pondinil, phenter-
mine, and mephetermine (9). In the guinea pig and
rabbit, there is little or no hydroxylation of am-
phetamine but the side chain is extensively de-
graded, and this is also the pattern ofmetabolism of
other amphetamines in these species.
(-CH2CH(NH2)CH2 r HO-T-CH2CH(NH2)CH3
guinea pig, rabbit
C6H5CH2 COH(NH2)CH3
I guinea pig
rabbit
C6H5CH2 COCH3- , C6H5COOH
rabbit
C6H5CH2 CHOH CH3
In chlorphentermine, the para position of am-
phetamine is blocked, and one could predict thatthe
rat would have difficulty in metabolizing
chlorphentermine, whereas the guinea pig and rab-
bit would attack the side chain. In fact, in the rat,
chlorphentermine is slowly excreted mainly un-
changed, whereas in the guinea pig and rabbit,
nearly half the chlorphentermine excreted is in the
form of metabolites in which the side chain NH2
group is oxidized mainly to N-hydroxychlorphe-
termine and its O-glucuronide (10).
QC>-CH2-CH-NH2
CH3
Amphetamine
CH3
Cl - CH2-C-NH2
CH3
Chlorphentermine
In the metabolism of amphetamines, neither the
rat northeguineapig is like man, butlimited dataon
the rhesus monkey and the tamarin suggest that
they metabolize amphetamine, norephedrine, and
phenmetrazine more like man than any other
species examined (11).
Comparative Metabolism of
Arylacetic Acids
The basic compound here is phenylacetic acid,
and it is known that this acid is metabolized by
conjugation of its carboxyl group mainly with
glutamine in man and monkeys (Old and New
World) and with glycine in lemurs and nonprimates.
COOH
o C6H5CH2CONHCHCH2CH2CONH2
49y
C6H5CH2COOH
C6H5CH2CONHCH2COOH
The question one can ask is, does this pattern apply
to other arylacetic acids and to all primates and
nonprimates? To answer such a question needs a
considerable amount ofwork to be done with diffe-
rent species receiving a variety of arylacetic acids.
In fact, the more species one studies, the more
complicated the picture tends to become.
Phenylacetic acid metabolism has been studied in
some 25 species, and in most of them it is largely
metabolized by conjugation, but in the Syrian ham-
ster it is also hydroxylated in the aromatic ring,
some 10% being converted to 3- or 4-hydroxy-
phenylacetic acid.
With five arylacetic acids, namely, phenyl-, p-
chlorophenyl-, p-nitrophenyl-, indol-3-yl-, and 1-
naphthylacetic acids, man and the rhesus monkey
are similar, but the pattern of conjugation depends
upon the arylacetic acid (see Table 1), since with
phenyl-,p-chlorophenyl- and indolylacetic acids, the
main conjugate in both species is the expected
glutamine conjugate, but with l-naphthylacetic acid
the glucuronic acid conjugate is formed, and with
p-nitrophenylacetic acid, no conjugate at all is
formed in either species.
Table 2 summarizes some recent work in this
laboratory on the conjugation of 1-naphthylacetic
acid in 14 species. Perusal of this table suggests
certain patterns. I-Naphthylacetic acid can be
conjugated at the carboxyl group with amino acids
and/or glucuronic acid, the amino acid conjugations
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% of24 hr excretion conjugated with
Arylacetic acid Species Glutamine Glycine Glucuronic acid
Phenylacetic acid Man 94 0 0
Rhesus monkey 32 1 0
p-Chlorophenylacetic acid Man 92 0 0
Rhesus monkey 45 1 0
p-Nitrophenylacetic acid Man 0 0 0
Rhesus monkey 0 0 0
Indol-3-ylacetic acid Man 15 0 30
Rhesus monkey 32 0
1-Naphthylacetic acid Man 0 6 95
(taurine)
Rhesus monkey 0 2 89
(taurine)
aData ofWilliams (1).
Table 2. Conjugation of 1-naphthylacetic acid in various species.a.b
% of 14C excreted conjugated with
Total Glucuronic
Species Glutamine Glycine Taurine amino acids acid
Man (5 mg/kg PO) 0 0 6 6 95
Old World monkeys
Rhesus 0 0 2 2 89
Cynomolgus 4 0 5 9 41
New World monkeys
Squirrel 5 21 21 47 21
Capuchin 4 4 36 44 17
Marmoset 2 3 13 18 70
Lemuroids
Bushbaby 0 53 11 64 17
Nonprimates
Carnivores
Dog 0 56 25 81 6
Ferret 0 7 63 70 26
Cat 0 59 40 99 0
Rodents
Rabbit 0 6 0 6 87
Rat 0 23 1 23 51
Bats
Indian fruit bat 0 0 0 0 94
aAnimal dose, 100 mg/kg, IM or IP.
bUnpublished data ofJ. Caldwell, P. A. F. Dixon, and J. R. Idle.
probably taking place in the mitochondria and the
glucuronic acid conjugation in the microsomes. The
data in Table 2 suggest that man and the Old World
monkeys conjugate it mainly with glucuronic acid,
the New World monkeys (except the marmoset)
and the bushbaby, mainly with amino acids and to
some extent with glucuronic acid, the carnivores
with amino acids extensively, the rodents mainly
with glucuronic acid, and the Indian fruit bat en-
tirely with glucuronic acid. It is tobe noted also that
the actual amino acid used varies between glycine
and taurine. Taurine conjugation is predominant in
carnivores and New World monkeys and glycine
conjugation also in the carnivores (dog and cat) and
the bushbaby. Table 2 shows that there are vague
patterns, but at the same time each species must be
treated separately. This is illustrated by the ferret
having the most extensive taurine conjugation and
February 1978 135the marmoset being more like man and the Old
World monkeys than the New World monkeys to
which it belongs.
Comparative Metabolism of
Phenols
It is well known that simple phenols are
metabolized and detoxicated by conjugation with
sulfate and glucuronic acid, but some common
species are known to have defects in these conjuga-
tions. The domestic cat, for example, has a defec-
tive glucuronic acid conjugation (12) which may
also occur in other members of the cat family such
as the lion, civet, and genet (13). In fact, the cat
seems to be more sensitive to phenol than other
common laboratory animals. The cat metabolizes
phenol by conjugation with sulfate. The pig, on the
other hand, seems to have adefective sulfate conju-
gation of phenol and metabolizes phenol by conju-
gation with glucuronic acid. These defects, how-
ever, are not universal for all phenols, since the cat
conjugates phenolphthalein more with glucuronic
acid than sulfate and the pig shows a substantial
sulfate conjugation of l-naphthol as shown in Table
3. The rat uses both conjugations almost equally
well with the phenols. It is to be noted that the pig
seems to distinguish between 1- and 2- naphthol, in
that 2-naphthol is almost entirely excreted as the
glucuronide whereas about a third of 1-naphthol is
eliminated as a sulfate. This type of observation
suggests that, in species variation studies, it is im-
portant to define specifically the substrate as well as
the species. Thus in the case of the cat, it is not
entirely true that it has a defective glucuronic acid
conjugation for all compounds that can form
glucuronides. A small number of compounds are
now known to be extensively conjugated with
glucuronic acid in the cat, e.g., diphenylacetic acid
which is conjugated to the extent of70%o ofthe dose
with glucuronic acid and hydratropic acid where the
conjugation is 40% (P. Dixon, J. Caldwell, R. L.
Smith, unpublished data).
An interesting observation on the conjugation of
1-naphthol in monkeys has recently been made in
this laboratory. In two species of Old World mon-
keys, the rhesus monkey and cynomolgus monkey,
[1-14C ]-l-naphthol (10 mg/kg) was found to be ex-
creted mainly as the sulfate conjugate, whereas in
two species of New World monkeys, the capuchin
and tamarin, the same dose was excreted mainly as
the glucuronide (see Table 4) (P. C. Hirom and
R. Mehta, unpublished data). This supports earlier
work on phenol (14) which was shown to conjugate
mainly with sulfate in the rhesus monkey and with
glucuronic acid in the capuchin and squirrel mon-
keys.
Table 4. ConjugatIon of [1-14C ]-1-naphthol in monkeys.a 6
% dose % of24 hr excretion of14C
excreted As As
Monkey (sex) in 24 hr sulfate glucuronide
Old World
Rhesus (IM, IF) 99, 101 83, 86 14, 12
Cynomolgus (IF) 97 76 23
New World
Tamarin (iM).- 84 15 84
Capuchin (2Ff 26, 32 2, 0 97, 99
aData ofP. C. Hirom and R. Mehta (unpublished).
bDose: 10 mg/kg, intramuscularly.
Dose and Pattern of
Drug Metabolism
The size of the dose of a xenobiotic could alter
the pattern ofits metabolism in sofaras alarge dose
could exhaust the mechanism by which a small dose
is metabolized. The compound could then be partly
Table 3. Conjugation of phenols with glucuronic acid (GA) and sulfate (S) in the rat, cat, and pig.'
% of24 hr excretion of labeled phenol
Rat Cat Pig
Conjugated Conjugated Conjugated Conjugated Conjugated Conjugated
Labeled with with with with with with
phenol GA S GA S GA S
Phenol 44 55 1 95 94 6
l-Naphthol 47 53 1 98 64 33
2-Naphthol 52 48 3 97 94 6
Phenacetinb 22 71 3 86 54 10
Phenolphthalein 60 40
aData ofWilliams (1).
bPhenacetin is excreted mainly as 4-acetamidophenol (acetaminophen).
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reaction. Changes in metabolic reactions are quite
common with phase 1I or conjugation reactions,
especially where certain conjugating agents are lim-
ited in supply, e.g., glycine and sulfate.
For example, it has been known for a consid-
erable time that in man and the pig, small doses of
benzoic acid are metabolized entirely by conjuga-
tion with glycine, but with large doses, glucuronic
acid conjugation become predominant (15). The
cat, as already mentioned, has a defective
glucuronic acid conjugation for certain compounds
including benzoic acid. Consequently, benzoic acid
is more toxic to the cat than most common species
of animals (16, 17), for the cat conjugates benzoic
acid entirely with glycine, which is limited in sup-
ply, and glucuronic acid conjugation is not available
to take over when large doses of benzoic acid are
administered. The effect ofdose on the glycine con-
jugation of phenylacetic acid in the ferret (J. R.
Idle, unpublished data) and of l-naphthylacetic acid
in the rat (J. Caldwell and P. Dixon unpublished
data) have been studied recently in this laboratory
in connection with taurine conjugation which is a
relatively new mechanism. Table 5 shows the pat-
tern ofconjugation ofphenylacetic acid in the ferret
with varying doses, and suggests that glycine con-
jugation is used mainly at the lowest dose, then as
the dose increases taurine conjugation becomes
evident and athigher doses stillglucuronic acid con-
jugation is also taking place. This suggests that
glycine tends to be exhausted first and then taurine
and finally glucuronic acid is utilized.
Table 5. Effect of dose on the conjugation of
phenylacetic acid in the ferret.a
% of24 hr excretion conjugated with
Dose, Glucuronic
mg/kg Glycine Taurine acid
0.01 69 8 0
100 63 21 0
200 41 38 4
400 36 33 10
aData of Idle (unpublished).
Table 6 shows the interesting case ofthe effect of
dose on the pattern of conjugates in the urine and
the bile of bile duct-cannulated rats receiving
1-naphthylacetic acid. Itis clearfrom the figures for
urine that glucuronic acid conjugation is taking over
from glycine conjugation as the dose rises, but for
the bile the pattern is practically unchanged for all
the doses. The bile pattern is explained by the fact
that l-naphthylacetylglucuronide (molecular weight
362) is extensively excreted in the bile in the rat,
whereas 1-naphthylacetylglycine (molecular weight
231) is not. The molecular weight ofthe glucuronide
is within the range 325 + 50 given by Hirom et al.
(18) for extensive biliary excretion in the rat,
whereas that of the glycine conjugate is below this
range, and this conjugate is unlikely to be excreted
in the bile in large quantities.
Table 6. Effect of dose on the urinary and biliary excretion of
conjugates of 1-naphthylacetic acid.a.b
% of3 hr excretion
Dose,
mg/kg
5
25
50
250
500
In urine In bile
Glucuronic Glucuronic
Glycine acid Glycine acid
conjugate conjugate conjugate conjugate
87 11 4 90
55 44 2 91
48 52 1 94
12 85 1 92
11 88 1 85
aData of P. A. F. Dixon and J. Caldwell (unpublished).
bBile duct-cannulated rats injected intraperitoneally. Molecu-
lar weights: 1-naphthylacetylglucuronide = 362; 1-
naphthylacetylglycine = 231.
Many other examples of changes in conjugation
with dose are to be found in the literature. Perhaps
a most interesting one is that ofp-acetamidophenol
(acetaminophen, panadol, paracetamol), which
produces liver necrosis in high doses. This drug
forms a sulfate, a glucuronide, and a mercapturic
acid. The toxic effect of high doses appears to be
related to the depletion of the liver of glutathione
which is used to form the mercapturic acid. Studies
in the hamster, a species most sensitive to the ne-
crotic effects of p-acetamidophenol, have shown
that at low doses more of the drug is excreted as
sulfur conjugates-sulfate and mercapturic acid-
-than glucuronide, but at high doses the reverse is
true (19).
It is clear from the study of the effect of dose on
glycine, sulfate, and glutathione conjugations that
these mechanisms have a limited capacity unless
supplemented from outside sources and that when
they are exhausted the glucuronic acid mechanism
takes over. It follows from this that, with any com-
pound which is detoxicated by conjugation with
glucuronic acid only, the pattern ofmetabolites will
not change very much with dose unless this is ex-
cessive. This has been found to be the case with
diphenylacetic acid and hydratropic acid
(2-methyl-2-phenylacetic acid) in the rat.
These acids are conjugated extensively with
glucuronic acid and at both low and high doses.
The metabolism of amphetamine in humans of
similar weight is much the same at 20 mg as at 100
mg per subject (20).
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Diphenylacetic acid (R=H)
Diphenylacetylglucuronide (R=C6H906)
CH3
<7 - CHCOOR Hydradratropic acid (R=H)
Hydratropoylglucuronide (R=C6H906)
In general, it seems probable that the extent of
metabolic pathways will change with increase in
dose, since it is to be expected that different
mechanisms have different capacities, and further-
more, some compounds can induce their own
metabolism and possibly one pathway more than
another. These changes, however, may also vary
with species as in the case ofthe cat with its defec-
tive glucuronic acid mechanism. Some effects of
high doses and continuous dosing ofcertain foreign
compounds are shown in Table 7.
Table 7. Toxic effect from high or continuous doses.
Compound Species Toxicity Probable cause
p-Acetamido-.
phenol Several Liver necrosis
Bromobenzene Several Liver necrosis Glutathione
Benzyl chloride Rat Growth depletion
inhibition
Naphthalene Rabbit Cataract
Benzoic acid Cat Poisoned Glycine depletion;
lack ofglucuronyl
transferase
Phenol Cat Poisoned Sulfate depletion;
lack ofglucuronyl
transferase
Nicotinamide Rat Growth "Methyl
inhibition deficiency"
The body can probably effectively detoxicate
"small and moderate doses" of the majority of
foreign compounds, although the magnitude of
"small and moderate doses" will vary with the
compound and the species. However, more work is
necessary to find out how many times a dose must
be increased before a change in metabolic pathway
occurs. Is the factor 2, 5, 10, 100, or more?
REFERENCES
1. Williams, R. T. Interspecies variations in the metabolism of
xenobiotics. Biochem. Soc. Trans. 2: 359 (1974).
2. Williams, R. T. Interspecies scaling. In: Pharmacology and
Pharmacokinetics. T. Teorell, R. L. Dedrick, and P. G.
Condliffe, Eds., Plenum Press, New York, 1974, p. 105.
3. James, M. O., et al. The conjugation ofphenylacetic acid in
man, sub-human primates and some non-primate species.
Proc. Roy. Soc. (London) B182: 25 (1972).
4. Adamson, R. H., et al. The fate of sulphadimethoxine in
primates compared with other species. Biochem. J. 118: 41
(1970).
5. Adamson, R. H., et al. Species differences in the aromatiza-
tion ofquinic acid and the role of gut bacteria. Biochem. J.
116: 437 (1970).
6. Gangolli, S. D., et al. Studies on the metabolism and
hepatotoxicity of coumarin in the baboon. Biochem. Soc.
Trans. 2: 310 (1974).
7. Wold, J. S., Smith, R. L., and Williams, R. T. Species vari-
ations in the O-methylation of n-butyl 4-hydroxy-3,5-di-
iodobenzoate. Biochem. Pharmacol. 22: 1865 (1973).
8. Pieper, W. A., and Skeen, M. J. Changes in blood methanol
concentrations in chimpanzees during periods of chronic
ethanol ingestion. Biochem. Pharmacol. 22: 163 (1973).
9. Williams, R. T., Caldwell, J., and Dring, L. G. Comparative
metabolism of some amphetamines in various species. In:
Frontiers in Catecholamine Research. E. Usden and S. H.
Snyder, Eds. Pergamon Press, Oxford, 1973, p. 927.
10. Caldwell, J., et al. Species variations in the N-oxidation of
chlorphentermine. Biochem. Pharmacol. 24: 2225 (1975).
11. Franklin, R. B., Dring, L. G., and Williams, R. T. The fate
of amphetamine and norephedrine in the tamarin monkey
compared with man. W. Afr. J. Pharmacol. Drug. Res. 2: 26
(1975).
12. Robinson, D., and Williams, R. T. Do cats form
glucuronides? Biochem. J. 68: 23P (1958).
13. French, M. R., et al. The conjugation of phenol, benzoic
acid, 1-naphthylacetic acid and sulphadimethoxine in the
lion, civet and genet. FEBS Letters 46: 134 (1974).
14. Capel, I. D., et al. The fate of14C-phenol in various species.
Xenobiotica. 2: 25 (1972).
15. Williams, R. T. Detoxication Mechanisms, 2nd Ed. Chap-
man and Hall, London, 1959, p. 349.
16. Bedford, P. G. C., and Clarke, E. G. C. Suspected benzoic
acid poisoning in the cat. Vet. Record. 1971: 599.
17. Bedford, P. G. C., and Clarke, E. G. C. Experimental ben-
zoic acid poisoning in the cat. Vet. Record 1972: 53.
18. Hirom, P. C., et al. Species variations in the threshold
molecular weight factor for the biliary excretion of organic
anions, Biochem. J. 129: 1071 (1972).
19. Jollow, D. J., et al. Effects of drug pretreatments on
acetaminophen-induced hepatic necrosis, glutathione deple-
tion, covalent binding and pattern of acetaminophen
metabolites in hamsters. Fed. Proc. 32: 305 (1973).
20. Sever, P. S., et al. The metabolism of amphetamine in de-
pendent subjects. Europ. J. Clin. Pharmacol. 6: 177 (1973).
138 Environmental Health Perspectives